Study limitation: This is a secondary analysis of a registered study (NCT06711952); the primary study protocol focused on SCD-Q validation, which may introduce selection bias | ReachRx
Diagnostic accuracy of a self-administered digital cognitive test battery for differentiating early Alzheimer’s disease from controls
Study limitation reported by the research below: “This is a secondary analysis of a registered study (NCT06711952); the primary study protocol focused on SCD-Q validation, which may introduce selection bias.”
